Understanding clinical decision-making in mesothelioma care: a mixed methods study
- PMID: 35840292
- PMCID: PMC9295667
- DOI: 10.1136/bmjresp-2022-001312
Understanding clinical decision-making in mesothelioma care: a mixed methods study
Abstract
Introduction: Malignant pleural mesothelioma is a rare, incurable cancer arising from previous asbestos exposure; patients have a poor prognosis, with a median survival rate of 8-14 months. Variation in mesothelioma clinical decision-making remains common with a lack of multidisciplinary knowledge sharing, leading to inconsistencies in treatment decisions. The study aimed to explore which factors impacted on clinicians' decision-making in mesothelioma care, with a view to optimising the mesothelioma care pathway.
Methods: This mixed methods study consisted of documentary analysis of local and national guidelines, policies or documents pertaining to mesothelioma care pathways, secondary analysis of mesothelioma patient data, and interviews with clinicians attending lung cancer and/or mesothelioma-specific multidisciplinary team meetings. The study took place at three National Health Service trusts in England. Documentations relating to patients' treatment pathways were collated and reviewed qualitatively. Records of patients with mesothelioma were extracted from hospital patient records and data collected on diagnosis date, treatment, mortality rates, survival postdiagnosis, age and clinical care team. Data were statistically analysed. Interviews with clinicians explored influences on clinical decision-making, including challenges or barriers involved. Data were thematically analysed. The Strengthening the Reporting of Observational Studies in Epidemiology reporting checklist was used.
Results: There were differences in the structure and delivery of mesothelioma treatment and care between trusts. Four main themes were identified: 'collaboration and communication', 'evidence base and knowledge', 'role of the clinician' and 'role of the patient'. Two cross-cutting themes relating to the role of the mesothelioma nurse specialist and the impact of COVID-19 were identified.
Discussion: There is a need to review the structure of mesothelioma multidisciplinary team meetings to ensure patients are reviewed by clinicians with appropriate knowledge, expertise and understanding of how, why and when decisions should be made. There is a need for expert clinicians in mesothelioma care to promote an up-to-date evidence and knowledge base within the wider multidisciplinary team.
Keywords: Asbestos Induced Lung Disease; Mesothelioma; Palliative Care; Pleural Disease; Rare lung diseases.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Recommendations for improving follow-up care for patients with mesothelioma: a qualitative study comprising documentary analysis, interviews and consultation meetings.BMJ Open. 2021 Jan 31;11(1):e040679. doi: 10.1136/bmjopen-2020-040679. BMJ Open. 2021. PMID: 33518517 Free PMC article.
-
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.Trials. 2014 Sep 19;15:367. doi: 10.1186/1745-6215-15-367. Trials. 2014. PMID: 25238873 Free PMC article. Clinical Trial.
-
Managing malignant pleural mesothelioma: experience and perceptions of health care professionals caring for people with mesothelioma.Support Care Cancer. 2019 Sep;27(9):3509-3519. doi: 10.1007/s00520-019-4648-0. Epub 2019 Jan 25. Support Care Cancer. 2019. PMID: 30684047
-
Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study.Southampton (UK): NIHR Journals Library; 2014 Oct. Southampton (UK): NIHR Journals Library; 2014 Oct. PMID: 25642498 Free Books & Documents. Review.
-
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.Crit Rev Oncol Hematol. 2016 Aug;104:9-20. doi: 10.1016/j.critrevonc.2016.05.004. Epub 2016 May 13. Crit Rev Oncol Hematol. 2016. PMID: 27286698
References
-
- Cancer Research UK. Statistics by cancer type. London: CRUK; 2019. https://www.cancerresearchuk.org/health-professional/cancerstatistics/st... [Accessed Sep 2021].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical